In this randomized placebo controlled intervention study, the effect of 12 weeks of supplementation with either 150g whole blueberries, freeze-dried blueberry powder (dose equivalent to 150g berries) versus placebo on cognitive functioning will be investigated in older adults.
Dementia is a public health priority. The prevalence of dementia is rapidly increasing due to population ageing, posing a great social and economic impact on caregivers, families and society. This, in combination with the lack of effective treatment options, demonstrates the urgent need for better understanding on how to prevent and slow down progression of this condition. As ageing and dementia are associated with increased levels of inflammation, nutritional compounds that exhibit anti-inflammatory properties may propose a solution. Blueberries, a good source of anthocyanins, have shown anti-inflammatory properties in several human trials. Therefore, in this randomized placebo controlled intervention study, we aim to investigate the effect of 12 weeks of supplementation with either 150g whole blueberries or freeze-dried blueberry powder (dose equivalent to 150g berries) versus placebo on cognitive functioning in overweight older adults with mild memory complaints. Secondary objectives include the assessment of whole blueberry and freeze-dried blueberry powder supplementation on inflammatory markers, oxidative stress, intestinal health markers, vascular and metabolic health markers, mental well-being, and levels of neurotransmitters.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Daily consumption of blueberries
Daily consumption of a freeze-dried blueberry powder
Daily consumption of a placebo powder
Verbal fluency
Performance on verbal fluency
Time frame: 12 weeks
Cognitive functioning
Rey Auditory Verbal Learning Test (RAVLT)
Time frame: 12 weeks
Cognitive function
Wechsler Digit Span Task (forward, backward, sequencing) WAIS-IV
Time frame: 12 weeks
Cognition
Symbol digit modalities test
Time frame: 12 weeks
Cognition
Trail Making Test (TMT) version A and B
Time frame: 12 weeks
Cognition
Stroop Color-Word test
Time frame: 12 weeks
Inflammation - CRP
Inflammatory blood marker: C-reactive protein
Time frame: 12 weeks
Inflammation - TNFalpha
tumor necrosis factor-alpha
Time frame: 12 weeks
Inflammation - IL6
interleukin-6
Time frame: 12 weeks
Oxidative stress
total plasma nitric oxide (NO)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 weeks
Oxidative stress
serum superoxide dismutase (SOD)
Time frame: 12 weeks
Intestinal health
Intestinal health markers as measured in blood and feces (microbiota composition, inflammatory fecal markers, microbiota-derived bioactive compounds, intestinal integrity markers
Time frame: 12 weeks
Metabolic health
Blood markers of metabolic health: plasma fasting glucose,
Time frame: 12 weeks
Metabolic health
Blood markers of metabolic health (plasma fasting glucose, Hb1Ac, triglyceride, adiponectin)
Time frame: 12 weeks
Metabolic health
Blood markers of metabolic health: Hb1Ac,
Time frame: 12 weeks
Metabolic health
Blood markers of metabolic health: triglyceride
Time frame: 12 weeks
Metabolic health
Blood markers of metabolic health: adiponectin
Time frame: 12 weeks
Mental well-being
Score on 12-item short form health survey
Time frame: 12 weeks
Mental well-being
profiles of mood states-short form (POMS)
Time frame: 12 weeks
Neurotransmitters
Levels of plasma neurotransmitters (dopamine, serotonin, (nor)adrenaline, and their metabolites)
Time frame: 12 weeks
Vascular health
Markers of vascular health (systolic blood pressure, diastolic blood pressure)
Time frame: 12 weeks